# The Clinical Cure Project of Chronic Hepatitis B in China

> **NCT04035837** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 30000 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** pegylated interferon-alfa

## Key facts

- **NCT ID:** NCT04035837
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-05-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 30000 (ESTIMATED)
- **Last updated:** 2025-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04035837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04035837, "The Clinical Cure Project of Chronic Hepatitis B in China". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04035837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*